loader2
Partner With Us NRI

Kilitch Drugs (India) Ltd share Price Today

Company details

345.75
367.50
247.50
470.00
6M Return -4.45%
1Y Return 40.60%
Mkt Cap.(Cr) 563.35
Volume 14,492
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 14,492
NSE

Invest in Market with Confidence: High performance strike rate of over 72%

Trade, sell, withdraw – all in minutes!
icon 27 Years

of legacy

icon 4.4 Star

App Rating

icon 1 Crore +

Customers

Open a Trading Account

Achieve your Investment goals today!

+91
Please enter valid Mobile Number
Get Started

Kilitch Drugs (India) Ltd shares SWOT Analysis

Strengths (7)

  • Effectively using its capital to generate profit - RoCE improving in last 2 years
  • Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
  • Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Weakness (4)

  • Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
  • Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
  • Declining Net Cash Flow : Companies not able to generate net cash

Opportunity (1)

  • Big Deal (Insider and SAST) buys last month greater than 1% of total shares

Threats (4)

  • Companies with growing costs YoY for long term projects
  • High PE (PE > 40)
  • Increasing Trend in Non-Core Income
Discover More

Resistance and support

R1 363.3
R2 376.3
R3 385.0
Pivot

354.52

S1 341.5
S2 332.8
S3 319.8
EMA SMA
362.6
354.6
351.1
338.6
363.1
352.9
344.5
362.6
Delivery and volume
Discover More
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
BP FINTRADE PRIVATE LIMITED Bulk Purchase 2018-03-06 96.36 78214 NSE
SHAH DIPAK KANAYALAL Bulk Sell 2018-03-06 96.35 66699 NSE
BP FINTRADE PRIVATE LIMITED Bulk Sell 2018-03-06 98.98 56811 NSE
Discover More
Name Category Shares
Bhavin Mukund Mehta PROMOTER 20.92%
Mukund Mehta PROMOTER 7.09%
Kilitch Company (Pharma) Limited PROMOTER 41.22%

FINANCIALS

Sales
Operating Profit
Profit after Tax
DISCOVER MORE
Equity
Reserves and Surplus
Debt
DISCOVER MORE
Sales
Operating Profit
Profit after Tax
DISCOVER MORE
PE
Debt/Equity
P BV
DISCOVER MORE

Kilitch Drugs (India) Ltd Stocks COMPARISON

Financials( ₹ in Cr) Kilitch Drugs (India) Ltd Sun Pharmaceuticals Industries Ltd Divis Laboratories Ltd Cipla Ltd Torrent Pharmaceuticals Ltd
Price 350.30 1,948.70 5,457.90 1,672.50 3,482.60
% Change -5.76 4.31 1.53 2.13 0.34
Mcap ₹ Cr 563.35 4,67,558.41 1,44,890.33 1,35,057.39 1,17,866.86
Revenue TTM ₹ Cr
DISCOVER MORE
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 176.29 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 18,682.45 57,359.48
LAST 3M 78,204.11 64,679.60
LAST 6M 1,86,853.49 86,996.15
LAST 12M 3,30,455.68 1,53,700.57

Kilitch Drugs (India) Ltd Information

No Data Found

No Data Found

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524500
NSE Code : KILITCH
Book Closure Date (Month) : Sep
BSE Group : B
ISIN : INE729D01010
Download App

Download Our App

Play Store App Store
market app

Open a Trading Account

Achieve your Investment goals today!

+91
Please enter valid Mobile Number
Get Started
Open a Trading Account